Home Business Wall Street Review: Tech Leads Stocks to New Highs in Broad Rally

Wall Street Review: Tech Leads Stocks to New Highs in Broad Rally

Share
wall-street-review:-tech-leads-stocks-to-new-highs-in-broad-rally
Wall Street Review: Tech Leads Stocks to New Highs in Broad Rally
Share

AD

The Epoch Times

A Fed rate cut, Musk’s $1 billion Tesla buy, Nvidia’s $5 billion Intel deal, and stronger-than-expected retail sales lift market sentiment.

Wall Street Review: Tech Leads Stocks to New Highs in Broad Rally

Stock market numbers are displayed at the New York Stock Exchange during morning trading on Sept. 17, 2025. Michael M. Santiago/Getty Images

Panos Mourdoukoutas

|Updated:

News Analysis

Technology shares led stocks to new highs this week, lifted by a long-awaited rate cut by the Federal Reserve, major tech investments, and stronger-than-expected retail sales.

Panos Mourdoukoutas

Panos Mourdoukoutas

Author

Panos Mourdoukoutas is a professor of economics at Long Island University in New York City. He also teaches security analysis at Columbia University. He’s been published in professional journals and magazines, including Forbes, Investopedia, Barron’s, IBT, and Journal of Financial Research. He’s also the author of many books, including “Business Strategy in a Semiglobal Economy” and “China’s Challenge.”

Author’s Selected Articles

Share
Related Articles
usda-unveils-new-support-for-ranchers-to-rebuild-cattle-herds
BusinessEconomyUSUS News

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new package of measures...

how-major-us-stock-indexes-fared-aug.-31
BrightBusinessInvestingMarketsPersonal FinanceStocks

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American forces struck Iranian...

trump-unveils-new-drug-pricing-deals-with-9-pharmaceutical-companies
BusinessCompaniesExecutive BranchUSUS NewsUS Politics

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...